Current filters:


7840 to 7849 of 96144 results

Boca generic version of Tapazole cleared by FDA


Florida, USA-based privately-held Boca Pharmacal said on Friday that it has received approval from the…

Boca PharmacalGenericsKing PharmaceuticalsMetabolicsNorth AmericaRegulationTapazole

XOMA's allosteric insulin receptor-activating antibody first to improve glycemic control in vivo


US therapeutic antibody discovery firm XOMA Corp (Nasdaq: XOMA) announced that results from a study of…

DiabetesPharmaceuticalResearchXmetAXOMA Corp

Canadian industry and government partner for health research and innovation


Leading national health research and innovation organizations in Canada have come together to form Research…

BiotechnologyHealthcareNorth AmericaPharmaceuticalResearch

Sanofi links with Spanish research institute on rare diseases


The Center for Genomic Regulation (Centre de Regulacio Genomica - CRG), a biomedical research institute…


More investment needed in anti-obesity drugs to appeal to growing market, says GlobalData report


Pharmaceutical companies should increase their investment in anti-obesity drug therapies to support the…

Markets & MarketingPharmaceuticalResearch

New pathway proposed for antibiotic approval in USA


The US Congress will consider a new drug approval pathway to encourage development of critically needed,…

Antibiotics and Infectious diseasesNorth AmericaPharmaceuticalRegulationResearch

NICE backs Merck & Co hep C drug Victrelis


UK drug watchdog the National Institute for Health and Clinical Excellence (NICE) has today (March 9)…

Anti-viralsEuropeMerck & CoPharmaceuticalPricingRegulationVictrelis

Unblinded Zytiga study meets endpoints in prostate cancer


Janssen Research & Development, a subsidiary of US health care giant Johnson & Johnson (NYSE: JNJ), has…

JanssenJohnson & JohnsonOncologyPharmaceuticalResearchZytiga

7840 to 7849 of 96144 results

Back to top